Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
The Kobe Journal of Medical Sciences|March 24, 2020
Fatal Hemoptysis Due to Endobronchial Aspergilloma in the Hyperinflated Native Lung after Single-Lung Transplantation for Lymphangioleiomyomatosis: A Case ReportAsuka Yoshizaki, Masatsugu Yamamoto, Aya Hirabayashi, et al.
Histopathology|August 13, 2018
Adenomatoid tumour of the uterus is frequently associated with iatrogenic immunosuppressionDaisuke Tamura, Daichi Maeda, Sultan Ahmad Halimi, et al.
Anticancer Research|August 27, 2011
Acquired drug resistance to vascular endothelial growth factor receptor 2 tyrosine kinase inhibitor in human vascular endothelial cellsTokuzo Arao, Kazuko Matsumoto, Kazuyuki Furuta, et al.
The Journal of Infectious Diseases|May 7, 2015
Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and ZanamivirDaisuke Tamura, Roberta L DeBiasi, Margaret Okomo-Adhiambo, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessmentDaisuke Tamura, Ha T Nguyen, Katrina Sleeman, et al.
Cancer Science|April 7, 2010
Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transitionDaisuke Tamura, Tokuzo Arao, Kaoru Tanaka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2011
Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitorsDaisuke Tamura, Norio Sugaya, Makoto Ozawa, et al.
Thoracic Cancer|February 21, 2024
Mechanism of action of adapalene for treating EGFR-TKI-induced skin disorderChihiro Mimura, Tatsuya Nagano, Nanako Miwa, et al.
Molecular Cancer Therapeutics|January 12, 2011
Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinomaTomoyuki Nagai, Tokuzo Arao, Kazuyuki Furuta, et al.
Cancer|September 8, 2018
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: Multicenter, single-arm, phase 2 trial (ABC Study)Akito Hata, Nobuyuki Katakami, Reiko Kaji, et al.
Pageof 11